Skip to content

Data Migration and Mapping Functions

Data Migration and Mapping Functions

Medical software does not have a good reputation for user experience and intuitive design. It can seem like a full-time job just learning how to use these software solutions.  In fact, according to a study from Stanford Medicine, 74% of doctors responded that their EMR increased the number of hours they work every day and 71% say their EMRs lead to physician burnout.  With this information, coupled with the increase use of telehealth (another software to learn), it’s no wonder that providers and their staff are looking for alternatives to simplify their clinical software, while not sacrificing the quality of patient care.

At Arfinn Med, we believe that your clinical software should be easy to use, fast and allow you to spend more time focusing on patient care rather than data entry. This focus on intuitive software design is why we are the leading EMR for alternative medicine clinics including practices focusing on cannabis and cannabinoid medicine.  Despite this, we still hear from providers who wish to switch to our platform that they are concerned about migrating data from paper charts or from another system.  We at Arfinn Med decided to address this concern.

We are proud to release our new secure data mapping software and a team of employees to focus on data migration.  This new system will allow us to speed up the time it takes to switch patient data, while also not interrupting your current practice workflows. You will also be assigned a team member from Arfinn to help with extraction of any additional data such as attached files, appointments and/or consents.

If you are interested in learning more about our data migration protocol, please reach out to us at info@arfinnmed.com.

Sincerely from quarantine,

The Arfinn Med Team

Stories you may be interested in

Substance in cannabis ‘could boost pancreatic cancer treatments’

A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More

Medical Marijuana a Hit With Seniors

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

Report of the Guideline Development Subcommittee of the American Academy of Neurology:   We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More

After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research

A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More

Leave a Comment